These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 3092622

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Spectrum of antiarrhythmic response to encainide.
    Duff HJ, Roden DM, Carey EL, Wang T, Primm RK, Woosley RL.
    Am J Cardiol; 1985 Nov 15; 56(13):887-91. PubMed ID: 3933319
    [Abstract] [Full Text] [Related]

  • 6. The effects of encainide and its major metabolites, O-demethyl encainide and 3-methoxy-O-demethyl encainide, on experimental cardiac arrhythmias in dogs.
    Kerr MJ, Allen JD, Harron DW, Shanks RG.
    J Cardiovasc Pharmacol; 1985 Nov 15; 7(3):449-57. PubMed ID: 2410673
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Antiarrhythmic activity, electrocardiographic effects and pharmacokinetics of the encainide metabolites O-desmethyl encainide and 3-methoxy-O-desmethyl encainide in man.
    Barbey JT, Thompson KA, Echt DS, Woosley RL, Roden DM.
    Circulation; 1988 Feb 15; 77(2):380-91. PubMed ID: 3123092
    [Abstract] [Full Text] [Related]

  • 9. Encainide. A review of its pharmacological properties and therapeutic efficacy.
    Brogden RN, Todd PA.
    Drugs; 1987 Nov 15; 34(5):519-38. PubMed ID: 3121275
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparative antiarrhythmic actions of encainide and its major metabolites.
    Gomoll AW, Byrne JE, Mayol RF.
    Arch Int Pharmacodyn Ther; 1986 Jun 15; 281(2):277-97. PubMed ID: 3092755
    [Abstract] [Full Text] [Related]

  • 12. Antiarrhythmic efficacy, clinical electrophysiology, and pharmacokinetics of 3-methoxy-O-desmethyl encainide (MODE) in patients with inducible ventricular tachycardia or fibrillation.
    Roden DM, Lee JT, Woosley RL, Echt DS.
    Circulation; 1989 Nov 15; 80(5):1247-58. PubMed ID: 2805262
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Total suppression of ventricular arrhythmias by encainide. Pharmacokinetic and electrocardiographic characteristics.
    Roden DM, Reele SB, Higgins SB, Mayol RF, Gammans RE, Oates JA, Woosley RL.
    N Engl J Med; 1980 Apr 17; 302(16):877-82. PubMed ID: 6767186
    [Abstract] [Full Text] [Related]

  • 16. [Acute and long-term antiarrhythmia effect of encainide in chronic atrial extrasystole].
    Thale J, Klein H, Shanks RG, Bender F.
    Z Kardiol; 1985 Apr 17; 74(4):220-7. PubMed ID: 2408392
    [Abstract] [Full Text] [Related]

  • 17. Comparative study of encainide and disopyramide in chronic ventricular arrhythmias: a double-blind placebo-controlled crossover study.
    Caron JF, Libersa CC, Kher AR, Kacet S, Wanszelbaum H, Dupuis BA, Poirier JM, Lekieffre JP.
    J Am Coll Cardiol; 1985 Jun 17; 5(6):1457-63. PubMed ID: 2582017
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.